BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 30995685)

  • 21. ¹¹C-methionine and ¹⁸F-fluorodeoxyglucose positron emission tomography/CT in the evaluation of patients with suspected primary and residual/recurrent gliomas.
    Li DL; Xu YK; Wang QS; Wu HB; Li HS
    Chin Med J (Engl); 2012 Jan; 125(1):91-6. PubMed ID: 22340472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 18F-FDOPA PET imaging of brain tumors: comparison study with 18F-FDG PET and evaluation of diagnostic accuracy.
    Chen W; Silverman DH; Delaloye S; Czernin J; Kamdar N; Pope W; Satyamurthy N; Schiepers C; Cloughesy T
    J Nucl Med; 2006 Jun; 47(6):904-11. PubMed ID: 16741298
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative evaluation of 18F-FDOPA, 13N-AMMONIA, 18F-FDG PET/CT and MRI in primary brain tumors - A pilot study.
    Jora C; Mattakarottu JJ; Aniruddha PG; Mudalsha R; Singh DK; Pathak HC; Sharma N; Sarin A; Prince A; Singh G
    Indian J Nucl Med; 2011 Apr; 26(2):78-81. PubMed ID: 22174511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Combined use of positron emission tomography with (18)F-fluorodeoxyglucose and (11)C-methionine for preoperative evaluation of gliomas].
    Yamaguchi S; Terasaka S; Kobayashi H; Narita T; Hirata K; Shiga S; Usui R; Tanaka S; Kubota K; Murata J; Asaoka K
    No Shinkei Geka; 2010 Jul; 38(7):621-8. PubMed ID: 20628188
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PET/CT using
    Liu D; Cheng G; Ma X; Wang S; Zhao X; Zhang W; Yang W; Wang J
    J Neuroimaging; 2021 Jul; 31(4):733-742. PubMed ID: 34021667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 18F-FDG PET/CT in primary brain lymphoma.
    Albano D; Bosio G; Bertoli M; Giubbini R; Bertagna F
    J Neurooncol; 2018 Feb; 136(3):577-583. PubMed ID: 29147860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical application of combination [
    Wang Z; Feng Z; Zhu D; Wang X; Chen J; Zhu Y; Wang H
    BMC Endocr Disord; 2024 Feb; 24(1):19. PubMed ID: 38311763
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinicopathological characteristics of primary central nervous system lymphoma with low 18F-fludeoxyglucose uptake on brain positron emission tomography.
    Kim HO; Kim JS; Kim SO; Chae SY; Oh SJ; Seo M; Lee SH; Oh JS; Ryu JS; Huh JR; Kim JH
    Medicine (Baltimore); 2020 May; 99(20):e20140. PubMed ID: 32443328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Imaging proliferation in brain tumors with 18F-FLT PET: comparison with 18F-FDG.
    Chen W; Cloughesy T; Kamdar N; Satyamurthy N; Bergsneider M; Liau L; Mischel P; Czernin J; Phelps ME; Silverman DH
    J Nucl Med; 2005 Jun; 46(6):945-52. PubMed ID: 15937304
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The correlation of
    Qu YH; Long N; Ran C; Sun J
    Clin Transl Oncol; 2021 Mar; 23(3):620-627. PubMed ID: 32683540
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined 68Ga-NOTA-PRGD2 and 18F-FDG PET/CT Can Discriminate Uncommon Meningioma Mimicking High-Grade Glioma.
    Li D; Zhang J; Ji N; Zhao X; Zheng K; Qiao Z; Li F; Lang L; Iagaru A; Niu G; Zhu Z; Chen X
    Clin Nucl Med; 2018 Sep; 43(9):648-654. PubMed ID: 30052597
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of F-18 FET-PET with F-18 FDG-PET for biopsy planning of non-contrast-enhancing gliomas.
    Plotkin M; Blechschmidt C; Auf G; Nyuyki F; Geworski L; Denecke T; Brenner W; Stockhammer F
    Eur Radiol; 2010 Oct; 20(10):2496-502. PubMed ID: 20521054
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Value of 18F-FDG and 11C-MET PET-CT in differentiation of brain ringlike-enhanced neoplastic and non-neoplastic lesions on MRI imaging].
    Cai L; Gao S; Li DC; Li YS; Chen QS; Xing XL
    Zhonghua Zhong Liu Za Zhi; 2009 Feb; 31(2):134-8. PubMed ID: 19538892
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of effects of 18F-FDG PET-CT and MRI in identifying and grading gliomas.
    Song PJ; Lu QY; Li MY; Li X; Shen F
    J Biol Regul Homeost Agents; 2016; 30(3):833-838. PubMed ID: 27655507
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Positron emission tomography imaging of brain tumors.
    Wong TZ; van der Westhuizen GJ; Coleman RE
    Neuroimaging Clin N Am; 2002 Nov; 12(4):615-26. PubMed ID: 12687915
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of
    Yi C; Shi X; Zhang X; Luo G; Zhang B; Zhang X
    Ann Nucl Med; 2019 Jan; 33(1):61-67. PubMed ID: 30350180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of 18F-FDG and 11C-methionine for PET-guided stereotactic brain biopsy of gliomas.
    Pirotte B; Goldman S; Massager N; David P; Wikler D; Vandesteene A; Salmon I; Brotchi J; Levivier M
    J Nucl Med; 2004 Aug; 45(8):1293-8. PubMed ID: 15299051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative study of (18)F-DOPA, (13)N-Ammonia and F18-FDG PET/CT in primary brain tumors.
    Jacob MJ; Pandit AG; Jora C; Mudalsha R; Sharma A; Pathak HC
    Indian J Nucl Med; 2011 Jul; 26(3):139-43. PubMed ID: 23326065
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    Zhou W; Wen J; Hua F; Xu W; Lu X; Yin B; Geng D; Guan Y
    Eur J Radiol; 2018 Jul; 104():26-32. PubMed ID: 29857862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PET Imaging of cerebral astrocytoma with 13N-ammonia.
    Xiangsong Z; Changhong L; Weian C; Dong Z
    J Neurooncol; 2006 Jun; 78(2):145-51. PubMed ID: 16739028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.